Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development

Abstract

Abstract. The in vivo metabolic clearance in human has been successfully predicted by using in vitro data of metabolic stability in cryopreserved preparations of human hepatocytes. In the predictions by human hepatocytes, the systematic underpredictions of in vivo clearance have been commonly observed among different datasets. The regression-based scaling factor for the in vitro-to-in vivo extrapolation has mitigated discrepancy between in vitro prediction and in vivo observation. In addition to the elimination by metabolic degradation, the important roles of transporter-mediated hepatic uptake and canalicular excretion have been increasingly recognized as a rate-determining step in the hepatic clearance. It has been, therefore, proposed that the in vitro assessment should allow the evaluation of clearances for both transporter(s)-mediated uptake/excretion and metabolic degradation. This review first outlines the limited ability of subcellular fractions such as liver microsomes to predict hepatic clearance in vivo. It highlights the advantages of cryopreserved human hepatocytes as one of the versatile in vitro systems for the prediction of in vivo metabolic clearance in human at the early development stage. The following section discusses the mechanisms underlying the systematic underprediction of in vivo intrinsic clearance by hepatocytes. It leads to the proposal for the assessment of hepatic uptake clearance as one of the kinetically important determinants for accurate predictions of hepatic clearance in human. The judicious combination of advanced technologies and understandings for the drug disposition allows us to rationally optimize new chemical entities to the drug candidate with higher probability of success during the clinical development.

Metabolite Profiling and Pharmacokinetic Evaluation of Hydrocortisone in a Perfused Three-Dimensional Human Liver Bioreactor

“…7 was rearranged into eq. 8 (Davies and Morris, 1993;Bayliss et al, 1999;Chiba et al, 2009;Chan et al, 2013):…”

Organic Anion Transporting Polypeptide (OATP)1B1 and OATP1B3 as Important Regulators of the Pharmacokinetics of Substrate Drugs

“…Using these approaches, several previous papers succeeded in the accurate prediction of in vivo hepatic clearance of several drugs from in vitro data. 14,15) However, looking into these data, though overall prediction accuracy of multiple drugs was fairly good within the range of 2-to 3-fold differences between the observed and predicted clearances, the hepatic clearances of some drugs could still not be accurately predicted from in vitro metabolism assays. One of the possible reasons for such discrepancy is the involvement of membrane transporters in the hepatic uptake of drugs.…”

Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies

“…An important aspect of PBPK modeling for compounds cleared primarily by the liver is the application of IVIVE methods to predict in vivo clearance from in vitro metabolic data. The utility of IVIVE for hepatic metabolic clearance has been well established in the literature [8][9][10] and is developing to improve poor predictions by incorporating hepatic uptake and/or biliary excretion [11,12]. Briefly, the in vitro intrinsic clearance (CL int ) or enzyme kinetic data (K m and V max ) are scaled to an in vivo CL int by accounting for the microsomal protein content or hepatocellularity and liver weight.…”